- On second try, Acadia drug gets nod from European regulatorsThe influential CHMP committee also threw its support behind more than a dozen other medicines while recommending the marketing authorization for Tavneos be revoked.BioPharma Dive · 1mo ago↗ source
- De-Risking a Rare Disease Launch Starts with PrecisionWhy traditional models fall short in rare disease commercialization—and what works instead.Fierce Biotech · 1mo ago↗ source
- Biopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and moreWelcome back to another edition of Endpoints Weekly! The summer solstice arrives this weekend — the northern hemisphere will reach its maximum tilt toward the sun at 4:24 a.m. Eastern time on Sunda…Endpoints · 1mo ago↗ source